NHS reforms

Publish date:

What next for the pharmaceutical industry? Among other changes implied by the UK government’s NHS reforms, prescribing will be more tightly controlled than ever; responsibility for public health will increasingly be with local government; and commissioning consortia will further alter the stakeholder landscape. The pharma industry needs to get ready by adjusting its commercial model. […]

What next for the pharmaceutical industry?

Among other changes implied by the UK government’s NHS reforms, prescribing will be more tightly controlled than ever; responsibility for public health will increasingly be with local government; and commissioning consortia will further alter the stakeholder landscape. The pharma industry needs to get ready by adjusting its commercial model.

Mike Sobanja, Chief Executive, NHS Alliance, shares his views with Capgemini’s Mark Holliday.

NHS_reforms.pdf

File size: 2.08 MB File type: PDF

Related Resources

GIS Analytics

Vegetation management can be one of the largest line items in your budget. But, constant...

The State of the Art in Agile Software Development

What is the latest in agile software development life cycle (SDLC)? This is a question we...

2020/2021 review of our first year on our road to net zero

In July 2020, we announced a strengthened commitment to sustainability with a new ambition to...